Massive blood disease registry launches in china
NCT ID NCT04645199
First seen Feb 13, 2026 · Last updated Jun 22, 2026 · Updated 16 times
Summary
This study is creating a large database of people with blood diseases in China, including leukemia, multiple myeloma, hemophilia, and others. Researchers will collect information from medical records and follow patients over time to see how these diseases develop, how they are treated, and what the outcomes are. The goal is to better understand these conditions and improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Hematology & Blood Diseases Hospital
RECRUITINGTianjin, Tianjin Municipality, 300000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could reveal better ways to diagnose, treat, and manage blood diseases in China, potentially improving patient care guidelines.
What could go wrong
This is an observational registry, not a treatment trial. It collects existing data and cannot prove what works best. Results may take years and might not apply outside China.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.